Skip to main content
Top
Published in: AIDS Research and Therapy 1/2020

Open Access 01-12-2020 | SARS-CoV-2 | Case Report

Case report: one case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a normal CD4+ T cell count

Authors: Wu Menghua, Zheng Xin, Liu Jianwei, Zhang Yu, Yao Qinwei

Published in: AIDS Research and Therapy | Issue 1/2020

Login to get access

Abstract

Background

The COVID-19 has been a severe pandemic all around the world. Nowadays the patient with co-infection of HIV and SARS-CoV-2 was rarely reported. Here we reported a special case with HIV and SARS-CoV-2 co-infection, which showed a prolonged viral shedding duration.

Case presentation

The patient was infected with HIV 8 years ago through sexual transmission and had the normal CD4+T cell count. She was found SARS-CoV-2 positive using real-time Polymerase Chain Reaction (RT-PCR) during the epidemic. Most importantly, the patient had a prolonged viral shedding duration of SARS-CoV-2 about 28 days.

Conclusion

The viral shedding duration may be prolonged in people living with HIV. The 14 days isolation strategy might not be long enough for them. The isolation or discharge of these patients needs further confirmation for preventing epidemics.
Literature
2.
go back to reference Ciotti MA, Minieri S, Giovannetti M, Benvenuto M, Pascarella DS, Sagnelli C, Bianchi M, Bernardini S, Ciccozzi M. COVID-19 outbreak: an overview. Chemotherapy. 2020;64:1–9. Ciotti MA, Minieri S, Giovannetti M, Benvenuto M, Pascarella DS, Sagnelli C, Bianchi M, Bernardini S, Ciccozzi M. COVID-19 outbreak: an overview. Chemotherapy. 2020;64:1–9.
3.
go back to reference Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497–506.CrossRef Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497–506.CrossRef
5.
go back to reference Lu Y, Li Y, Deng W, Liu M, He Y, Huang L, et al. Symptomatic infection is associated with prolonged duration of viral shedding in mild coronavirus disease 2019: a retrospective study of 110 children in Wuhan. Pediatr Infect Dis J. 2020;39(7):e95–9.PubMedPubMedCentral Lu Y, Li Y, Deng W, Liu M, He Y, Huang L, et al. Symptomatic infection is associated with prolonged duration of viral shedding in mild coronavirus disease 2019: a retrospective study of 110 children in Wuhan. Pediatr Infect Dis J. 2020;39(7):e95–9.PubMedPubMedCentral
7.
go back to reference Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (Full version). New Med. 2020;30:35–64. Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (Full version). New Med. 2020;30:35–64.
8.
go back to reference Mao ZQ, Wan R, He LY, Hu YC, Chen W. The enlightenment from two cases of asymptomatic infection with SARS-CoV-2: is it safe after 14 days of isolation? Int J Infect Dis. 2020;95:174–5.CrossRef Mao ZQ, Wan R, He LY, Hu YC, Chen W. The enlightenment from two cases of asymptomatic infection with SARS-CoV-2: is it safe after 14 days of isolation? Int J Infect Dis. 2020;95:174–5.CrossRef
9.
go back to reference Zhang WY, Yu LQ, Huang JA, Zeng DX. Prolonged viral RNA shedding duration in COVID-19. Am J Ther. 2020;10:1097. Zhang WY, Yu LQ, Huang JA, Zeng DX. Prolonged viral RNA shedding duration in COVID-19. Am J Ther. 2020;10:1097.
10.
go back to reference Huang J, Lin H, Wu Y, Fang Y, Kumar R, Chen G, Lin S, et al. COVID-19 in post-transplantation patients-report of two cases. Am J Transplant. 2020;20(7):1879–81.CrossRef Huang J, Lin H, Wu Y, Fang Y, Kumar R, Chen G, Lin S, et al. COVID-19 in post-transplantation patients-report of two cases. Am J Transplant. 2020;20(7):1879–81.CrossRef
13.
go back to reference Mahnke YD, Fletez-Brant K, Sereti I, Roederer M. Reconstitution of peripheral T cells by tissue-derived CCR4 + central memory cells following HIV-1 antiretroviral therapy. Pathog Immun. 2016;1(2):260–90.CrossRef Mahnke YD, Fletez-Brant K, Sereti I, Roederer M. Reconstitution of peripheral T cells by tissue-derived CCR4 + central memory cells following HIV-1 antiretroviral therapy. Pathog Immun. 2016;1(2):260–90.CrossRef
Metadata
Title
Case report: one case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a normal CD4+ T cell count
Authors
Wu Menghua
Zheng Xin
Liu Jianwei
Zhang Yu
Yao Qinwei
Publication date
01-12-2020
Publisher
BioMed Central
Published in
AIDS Research and Therapy / Issue 1/2020
Electronic ISSN: 1742-6405
DOI
https://doi.org/10.1186/s12981-020-00301-3

Other articles of this Issue 1/2020

AIDS Research and Therapy 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine